What is NDC 82682-001?

82682-001 is the product NDC for Kourzeq (triamcinolone acetonide), Triamcinolone acetonide 1 mg/g paste, listed with the FDA by MidAmerica Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Kourzeq (Triamcinolone Acetonide).

MidAmerica Pharmaceuticals, NDC labeler code 82682. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Kourzeq?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Kourzeq NDC 82682-001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)82682-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82682-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82682-001-05	82682000105	1 TUBE in 1 CARTON (82682-001-05) / 5 g in 1 TUBEMarketed from Sep 15, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Kourzeq
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — 1 mg/g
Dosage form: Paste
Route: Topical
Labeler: MidAmerica PharmaceuticalsNDC labeler code 82682
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040771
Marketing start: Sep 15, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 82682-001_7aad2f23-85cb-4228-8460-aef6676cc11fSPL ID 7aad2f23-85cb-4228-8460-aef6676cc11fSPL set ID aad48d1e-f8db-4020-92af-0b3258bbc0f2RxCUI 1085728, 2665617UNII F446C597KA
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482682000105 followed by a unit qualifier and the quantity

Package 82682-0001-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 18, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE KOURZEQ is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 82682-001

What is NDC 82682-001?: 82682-001 is the product NDC for Kourzeq (triamcinolone acetonide), Triamcinolone acetonide 1 mg/g paste, listed with the FDA by MidAmerica Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Kourzeq (Triamcinolone Acetonide).
What is the active ingredient?: Triamcinolone acetonide.
Who is the labeler?: MidAmerica Pharmaceuticals, NDC labeler code 82682. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Kourzeq?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 040771

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040771
Product	Strength	Form · route	Labeler	Product NDC
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	PasteTopical	Preferred Pharmaceuticals, Inc.	68788-8386
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	PasteTopical	Rising Pharma Holdings, Inc.	64980-320

Kourzeq (Triamcinolone acetonide) NDC 82682-001